Multi-Layered Body Contouring Technology:

A Game-Changing Innovation in Aesthetic Medicine

Ulvera AI specializes in non-invasive aesthetic medical technology, offering a hands-free device for precise fat reduction, skin tightening, and muscle stimulation. The company’s solutions are based on personalized treatments with visible results in a short number of sessions.

Join the Revolution of Aesthetics

The Problem

Ulvera AI is solving the problem of ineffective and invasive body contouring treatments by its proprietary Quasi Focused Ultrasound technology that delivers consistent, personalized results without the discomfort and downtime associated with traditional surgical procedures.

The Vision

Delivering comprehensive technology for consistent, reproducible clinical results without side effects.

The Mission

To advance and redefine body contouring and skin tightening technologies.

The global Energy Based Body Contouring market is 7.5 Billion USD growing at CAGR of 14%!

2 working prototypes and 3 patents!

Initial clinical trial conducted with 22 patients in both Israel and the US, led by industry experts

Join the revolution of Aesthetics!
Cutting edge technology

The only ultrasound based technology working on ALL needed tissue layers for effective Body Contouring.
The system changes the ultrasonic beam parameters & energy deposition depth according to the patient’s specific need.

The system treats the dermis, subcutaneous fat, superficial fascia & stimulates the muscle.

Ulvera technology is hands free. Offers combined fat destruction, skin tightening and muscle stimulation.

Treats superficial fat layer & superficial fascia layer at the right depth.

Reduction in fat layer thickness ranging from 18 to 27%. Mean value: 23%.

4 applicators operated simultaneously.

Personalized treatment based on ultrasound imaging.

Decrease in waist size up to 12 cm after 3 treatments (6 month).

Combined ultrasonic and EMS.

Globally recognized experts with diverse backgrounds, including physicians, engineers, and market leaders.

Founders

Dr. Ines Verener, CEO

Dermatologist and former president of the European Society of Cosmetic & Aesthetic Dermatology ESCAD, Former President of the Israel Society for Dermatologic Surgery.

Dr. Yoram Eshel, CBO

Past founder & CEO of Ultrashape. Past senior marketing director of body shaping products at Lumenis

Dr. Boris Vaynberg, CTO

Former CTO Venus concept & former VP R&D Syneron Candela

Advisory Board & Investors

DR GRANT STEVENS, MD

Board Certified Plastic Surgeon, USA Past president of the Aesthetics Society ASAPS Medical Director of Marina Plastic Surgery and Marina MEDSPA

DR PETER PENG, MD

Board Certified Dermatologist/ Dermatological surgeon, Taiwan. President – Laser and Photonics Medicine Society of Taiwan (LMSTW), Executive Director Taiwanese Dermatological Association (TDA), Past President Taiwan Society of Hair Restoration Surgery (TSHRS)

DR MICHAEL GOLD, MD

Board Certified Dermatologist and cosmetic surgeon, USA. Founder, Gold Skin Care Center, Nashville TN. Assistant Professor, Vanderbilt University. Visiting Professor of Dermatology for Huashan Hospital, Fudan University in Shanghai, China.

DR JASON POZNER, MD

Board Certified Plastic Surgeon, USA. Founder Sanctuary Plastic Surgery, Co-owner Sanctuary Medical Aesthetic Center, Boca Raton FL.

DR BARRY DIBERNARDO, MD

Board Certified Plastic Surgeon, USA. Medical Director of New Jersey Plastic Surgery, Montclair, NJ. Past President of the New Jersey Society of Plastic Surgeons (2005-06). Associate Clinical Professor in Plastic and Reconstructive surgery at IMDNJ. Board member of the Aesthetic Surgery Education and Research Foundation.

DR KLAUS FRITZ, MD

Board Certified Dermatologist, Germany Founder and director of Dermatology and Laser consultation Center , Landau (Germany Associate Univ. Professor at the University of medicine and pharmacy "Carol Davila” Past President ESLD (European Society of Lasers in Dermatology).

DR YOUNGHOON CHO, MD PHD

Board Certified Plastic Surgeon Founder of Integrated Aesthetics in Spring TX Trainer for Allergan & Galderma.

become an Investor

Fill in the form and we will be in touch

Regulations may change periodically, and the latest version will apply.

By confirming that you meet one of the criteria mentioned below, you acknowledge that HiFund relies on your statement to grant access to limited information in this website.

Individual Accreditation

  1. Liquid Assets: You own liquid assets (including stocks, bonds, mutual investment funds, and ‘kranot hishtalmut’) worth over NIS 8,364,177.
  2. Annual Income: Your annual income for each of the previous two years exceeds NIS 1,254,627.
  3. Liquid Assets and Annual Income: You own liquid assets worth in total more than NIS 5,227,610, and your annual income for each of the previous two years is at least NIS 627,313.

Joint Accreditation with Spouse

  1. Joint Annual Income: Your joint annual income for each of the previous two years is over NIS 1,881,940.
  2. Liquid Assets and Joint Annual Income: You own liquid assets worth in total more than NIS 5,227,610, and your joint annual income for each of the previous two years exceeds NIS 940,969

 

Corporate Accreditation

1. Equity Requirement: The investor is an entity with equity exceeding NIS 50,000,000 (excluding entities formed solely for purchasing securities in a specific offering).

2. Qualified Investor Ownership: The investor is an entity fully owned by entities and/or individuals who meet the Qualified Investor criteria specified in Art. 15A(b)(1) and Schedule 1 of the Securities Law. Each shareholder (individual or entity) must complete Investor Qualification Forms to verify their eligibility.

3. Israeli Entity Classification: The investor is one of the following entities organized under the laws of Israel:

a. Portfolio Manager: A portfolio manager as defined in the Regulation of Investment Advice, Investment Marketing, and Investment Portfolio Management 5755-1995, purchasing for themselves or on behalf of clients who are investors listed in section 15A(b) of the Securities Law.

b. Investment Advisor: An investment advisor as defined in the Regulation of Investment Advice, Investment Marketing, and Investment Portfolio Management 5755-1995, or an investment marketing agent purchasing for themselves.

c. Underwriter: An underwriter satisfying the conditions set forth in Section 56(c) of the Securities Law, purchasing for themselves.

d. Joint Investment Fund: A joint investment fund or its managing company as defined in the Joint Investment Trust Law 5754-1994.

e. Provident Fund: A provident fund or its managing company as defined in the Regulation of Financial Services (Provident funds) Law 5765-2005.

f. Venture Capital Fund: A venture capital fund, which is a corporation primarily engaged in investing in research and development or the manufacturing of innovative and hi-tech products or processes, where the investment risk is higher than customary for other investments.

Skip to content